Suspended
A French Non Interventional Multicentric Cohort Study in Patients With Colorectal Dysplasia in Intestinal Inflammatory Diseases
What is being collected
Data Collection
Collected from today forward - ProspectiveNo DNA Sample
Who is being recruted
Pathologic Processes
+ Pathological Conditions, Signs and Symptoms
+ Hyperplasia
From 18 to 80 Years
+9 Eligibility Criteria
How is the trial designed
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Observational
Study Start: July 2013
Summary
Principal SponsorHôpital Edouard Herriot
Last updated: September 21, 2023
Sourced from a government-validated database.Claim as a partner
Study start date: July 1, 2013
Actual date on which the first participant was enrolled.A replay centralized pathological lesion slides corresponding to the different lesion will be done
Principal SponsorHôpital Edouard Herriot
Last updated: September 21, 2023
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
300 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sex
Biological sex of participants that are eligible to enroll.From 18 to 80 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Pathologic ProcessesPathological Conditions, Signs and SymptomsHyperplasia
Criteria
5 inclusion criteria required to participate
compliant patient
endoscopic follow possible
intestinal chronic inflammatory disease with at least one lesion such as hyperplasia or no dysplastic scalloped lesion, dysplastic scalloped lesion or low grade dysplasia or high grade dysplasia
no serious pathology such as cancer
Show More Criteria
4 exclusion criteria prevent from participating
endoscopic follow not possible
no compliant patient
serious pathology such as cancer
settler cancer
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Treatment Groups
Study Objectives
One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
SuspendedOne Study Center